Health
Persistent immune thrombocytopaenic purpura associated with SARS‐CoV‐2 infection – Wiley
Click on the article title to read more.
We describe evolution of persistent immune thrombocytopaenic purpura (ITP) from acute ITP in a young woman with clinically otherwise inapparent severe acute respiratory syndrome coronavirus 2 (SARSCoV2) infection (COVID19); her development of ITP was matter for an earlier report.[1] ITP is an acquired disease in which thrombocytopaenia results from autoantibodies against platelet antigens. Approximately 10% of patients with acute ITP develop persistent (lasting 312 months) or chronic (>12 months)…
-
Noosa News22 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
Noosa News21 hours agoWoman loses arm in lion attack at Darling Downs Zoo in Queensland
-
General23 hours agoEV buses join Perth’s wider suburban network, ‘milestone’ for diesel phase-out
-
Noosa News20 hours agoMissing man, Maroochydore – Queensland Police News